Rationelle Diagnostik der erektilen Dysfunktion unter Anwendung eines pharmakologischen Testes

@article{Bhren1986RationelleDD,
  title={Rationelle Diagnostik der erektilen Dysfunktion unter Anwendung eines pharmakologischen Testes},
  author={W. B{\"a}hren and C. Stief and W. Scherb and H. Gall and A. Gallwitz and J. Altwein},
  journal={Aktuelle Urologie},
  year={1986},
  volume={17},
  pages={177-180}
}
Bei 100 multidisziplinar untersuchten Patienten mit mindestens 1jahriger erektiler Dysfunktion (E. D.) wurde zu diagnostischen Zwecken ein pharmakologisches Testverfahren mit intrakavernoser Applikation eines Papaverin-Phetolamingemisches angewandt. Aufgrund dieses pharmakologischen Testes gelingt eine Einordnung in 1. nichtvaskular bedingte E. D., 2. vaskulare E. D. mit pathologischen inflow-Bedingungen und 3. vaskulare E. D. mit pathologischen outflow-Bedingungen. Gruppe I (n = 13) erreichte… Expand
Stellenwert von Prostaglandin E 1 (PGE 1 ) in der Diagnostik und Therapie der erektilen Dysfunktion
Die intrakavernose Testung mit vasoaktiven Substanzen wie Papaverin bzw. Papaverin/Phentolamin ist seit der Publikation von Virag 1982 im Lancet [27] zunehmend in den Mittelpunkt des diagnostischenExpand
Postersitzung 11: Erektile Dysfunktion
TLDR
Klinische Beobachtungen haben gezeigt, das Zigarettenrauchen eine wichtige pathogenetische Rolle bei der erektilen Dysfunktion spielt, ohne das zusatzliche Papaverin-Phentolamin-Injektionen notwendig gewesen waren. Expand
Urologische Langzeitbetreuung von Patienten mit Meningomyelozele II. Therapie
Verschiedene urologische therapeutische Moglichkeiten stehen fur Patienten mit Meningomyelozele zur Verfugung. Die jeweilige Therapie mus sich nach der gegenwartigen Situation derExpand
Differentialdiagnose und Behandlung Somatischer und Funktioneller Formen der Diabetischen Erektilen Impotenz
TLDR
Eine multidisziplinare Abklarung einschlieslich Erektionstestung mit intracavernoser Applikation vasoaktiver Substanzen erlaubt die Kausalgenese der erektilen Dysfunktion nachzuweisen und adaquate therapeutische Masnahmen einzuleiten. Expand
PotassiumParaaminobenzoate ( POTABATM ) in theTreatment of Peyronie ’ s Disease : AProspective , Placebo-Controlled , Randomized Study
Purpose: The aim of this study was to investigate the effect of potassium paraaminobenzoate (Potaba) in Peyronie’s disease in a prospective, randomized, double-blind, placebo-controlled, multicentreExpand
The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience.
  • H. Porst
  • Medicine
  • The Journal of urology
  • 1996
TLDR
For self-injection therapy, P GE1 presently represents the most efficacious and safest drug and Ongoing trials with topical and especially intraurethral PGE1 are promising and may offer less invasive therapies in the near future. Expand
Penile perfusion and functional scintigraphy: preliminary clinical results before and after microsurgical revascularization.
TLDR
Penile vascularization using the Hauri method provides an objectively demonstrable improvement in penile haemodynamics in man and is thus a sufficiently therapeutic procedure for treating erectile dysfunction of vascular aetiology and its effect greatly exceeds any 'psychological influence'. Expand
Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study.
TLDR
Potassium paraaminobenzoate appears to be useful to stabilize the disorder and prevent progression of penile curvature and a significant protective effect on deterioration of peniles curvature could be demonstrated. Expand
Arterial anatomy and arteriographic diagnosis of arteriogenic impotence
TLDR
The results of the morphologic studies of the vascular system are correlated with functional testing of erectile capacity by intracavernous application of a papaverinephentolamine drug combination. Expand
Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
TLDR
Intracavernous injection of prostaglandin E1 is a potent tool for artificial penile erection and warrants precise examination for its potential clinical use. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 26 REFERENCES
Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.
TLDR
Coital penetration was possible in 59 of 62 patients with impotence of divers etiologies who underwent injection and were sent home to attempt coitus, and Administration should be restricted to urologists able to manage the possible complication of priapism. Expand
Intracavernous Injection of Papaverine as a Diagnostic and Therapeutic Method in Erectile Failure
TLDR
Erections improved significantly in 66% of the patients with a mean follow up of one year, and a strong vasodi lation in the penile arteries and a diminished outflow from the cavernous bodies was shown. Expand
Diagnostic tests for impotence: a comparison of papaverine injection with the penile-brachial index and nocturnal penile tumescence monitoring.
TLDR
It is concluded that the intracorporeal injection of papaverine currently is the best screening technique for the differential diagnosis of vasculogenic impotence. Expand
Effect of local alpha-adrenergic blockade on human penile erection.
TLDR
The organic nature of the impotence was documented with nocturnal penile tumescence testing, sacral latency examination, Doppler penile blood flow measurements, hormonal evaluation and psychological testing, and possible mechanisms are discussed. Expand
Diagnosis and Treatment of Erectile Impotence
Solid scientific information on the psychophysiological mechanisms of human erection and impotence is meager, so the clinician has little but clinical experience and largely anecdotal literature toExpand
Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence.
  • G. Brindley
  • Medicine
  • The British journal of psychiatry : the journal of mental science
  • 1983
TLDR
Intravacernosal injection of phenoxybenzamine caused full erection lasting between half an hour and 30 hours in 30 of 4 potent men and in 6 of 11 impotent men, who have had sexual intercourse, for the first time for months or years, while under the drug. Expand
Comprehensive laboratory evaluation of impotent men.
TLDR
Of the 27 impotent men examined, 48 per cent had a combination of neurologic, psychiatric and vascular abnormalities, and a definite cause-and-effect relationship between these abnormalities and impotence has not been established. Expand
The importance of penile blood pressure in cases of impotence.
  • P. Gaskell
  • Medicine
  • Canadian Medical Association journal
  • 1971
TLDR
It appears that the normal penile systolic blood pressure is equal to or greater than the calculated brachial mean blood pressure, and obstruction to blood flow was identified as a cause of impotence in patients with little other evidence of peripheral vascular disease. Expand
A Placebo Controlled Double Blind Study of the Effect of Intracavernous Injection of Phenoxybenzamine in the Diagnosis and Management of Organic Impotence
  • J . Urol .
  • 1985
Cartagena : Intracavernous Injection of Two Vasoactive Drugs for Impotence : The Buffalo Experience
  • J . Urol .
  • 1985
...
1
2
3
...